Latest news from the Centre for Precision Cell Therapy for the Liver (PRaCTicAL) POC-DILI trial opens to recruitment Point-of-care assessment of drug-induced liver injury (POC-DILI) aims to develop blood testing for liver injury following paracetamol overdose. October 24. Professor Shareen Forbes and Dr Lisa White awarded funding for research into improving islet transplantation As part of the Type 1 Diabetes Grand Challenge, Professor Shareen Forbes, at the University of Edinburgh, and Dr Lisa White, at the University of Nottingham have been awarded funding from the Steve Morgan Foundation to investigate innovative ways of improving islet transplantation for the treatment of Type 1 diabetes (T1D). Exploring views on current and future treatments for Type 1 Diabetes People and Insulin Therapies: Concerns and Hopes (PITCH) aims to explore participants’ ideas, concerns, expectations, met and unmet needs in relation to their Type 1 diabetes, and explore views of islet transplantation as a treatment for Type 1 diabetes. May 2024 MAIL trial opens to recruitment Macrophage Therapy For Acute Liver Injury (MAIL) Phase 1 trial aims to assess the safety and tolerability of macrophage cell therapy in acute liver injury (ALI) following paracetamol overdose. January 2024 This article was published on 2024-10-07
